EL PASO, TX--(Marketwired - Oct 6, 2016) - Premier Biomedical, Inc (
Greetings from the CEO and Staff at Premier Biomedical, Inc.
I would like to take this opportunity to update you, our shareholders, on significant developments at Premier Biomedical, Inc. through the third quarter of 2016:
COMPANY BALANCE SHEET & SHARE STRUCTURE.
We understand that we cannot continue to borrow money on a long term basis to fund ongoing research and development.
PARTNERSHIP STRATEGY/STATUS
We believe that our corporate focus should continue to be on development efforts in two principal product groupings: 1) BIOLOGICS (Immunotherapy/Extracorporeal Treatments) and 2) PAIN MANAGEMENT.
BIOLOGICS GROUP PROGRAM PROGRESS
PAIN MANAGEMENT GROUP PROGRAM PROGRESS
CORPORATE MANAGEMENT CHANGES/ADDITIONS
STOCK SUPPORT ACTIONS
SUMMARY
You can keep up to date on our progress by visiting our website (www.premierbiomedical.com), or subscribing to our email list (http://www.premierbiomedical.com/contact-us/). We encourage you to share our progress with your friends, relatives, and associates.
I remain respectfully yours,
William A. Hartman
President & CEO
Premier Biomedical, Inc.
Contact Info: (724) 633-7033, [email protected]
Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Premier Biomedical, Inc. cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Premier Biomedical, Inc. undertakes no obligation to revise these statements following the date of this news release.
William A. Hartman
President & CEO
Premier Biomedical, Inc.
Contact Info: (724) 633-7033
[email protected]
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member